Athira Pharma, Inc. Class Action Lawsuit - ATHA

Company
Athira Pharma, Inc. (NASDAQ: ATHA)
Lead Plaintiff Deadline
August 24, 2021 (Expired)
Class Definition
Athira Pharma, Inc. securities between September 18, 2020 and June 17, 2021 and/or purchased common stock of Athira in or traceable to the Company’s registration statement issued in connection with the Company’s September 2020 initial public offering priced at $17.00 per share.

Expired

Lead Plaintiff Deadline

Aug 24, 2021

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

(1) the research conducted by Defendant Kawas, which formed the foundation for Athira’s product candidates and intellectual property, was tainted by Kawas’ scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.

Eligibility

In order to be eligible to join the ATHA class action lawsuit, you must have incurred a loss on shares of Athira Pharma purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Athira Pharma during the relevant time frame, you have until August 24, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

TOP